← Back to Clinical Trials
Recruiting NCT05192759

NCT05192759 Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Freezing of Gait

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05192759
Status Recruiting
Phase
Sponsor Anhui Medical University
Condition Transcranial Magnetic Stimulation
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2021-11-22
Primary Completion 2028-12-30

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Transcranial Magnetic Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2021-11-22 with a primary completion date of 2028-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To investigate the treatment effect of Theta-burst Transcranial Magnetic Stimulation (TBS) on patients with freezing of gait (FOG) and the underlying neural mechanism.

Eligibility Criteria

Inclusion Criteria: 1. diagnosis of FOG with expertise in movement disorders. 2. the score of item 3 of the FOG questionnaire ≥1. 3. ongoing treatment with a stable dose of any medication for 2 months. 4. 40 years of age or older. Exclusion Criteria: 1. a history of addiction, psychiatric disorders, or neurological diseases other than PD. 2. focal brain lesions on T1-/T2-weighted fluid-attenuated inversion recovery images. 3. anti-PD medication adjustments during rTMS treatment. 4. history of substance abuse within the past 6 months. 5. nonremovable metal objects in or around the head. 6. previously received rTMS treatment. 7. prior history of seizure or history in first-degree relatives.

Contact & Investigator

Central Contact

Gong-Jun JI, Ph.D.

✉ jigongjun@163.com

📞 +8655162923704

Frequently Asked Questions

Who can join the NCT05192759 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 85 Years, studying Transcranial Magnetic Stimulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05192759 currently recruiting?

Yes, NCT05192759 is actively recruiting participants. Contact the research team at jigongjun@163.com for enrollment information.

Where is the NCT05192759 trial being conducted?

This trial is being conducted at Hefei, China.

Who is sponsoring the NCT05192759 clinical trial?

NCT05192759 is sponsored by Anhui Medical University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology